Zhang Dongdong

Prof. Zhang Dongdong

Department of Oncology, Hubei University of Medicine, Shiyan, Hubei, China
orcid

Biography

1. "The novel thioredoxin reductase inhibitor A-Z2 triggers intrinsic apoptosis and shows efficacy in the treatment of acute myeloid leukemia." Free Radic Biol Med 146: 275-286. 2. Azelaic Acid Exerts Antileukemia Effects against Acute Myeloid Leukemia by Regulating the Prdxs/ROS Signaling Pathway. Oxidative medicine and cellular longevity. 2020;2020:1295984. 3.“Antiproliferative and Immunoregulatory Effects of Azelaic Acid Against Acute Myeloid Leukemia via the Activation of Notch Signaling Pathway.” Front Pharmacol. 4. Pygo2 as a novel biomarker in gastric cancer for monitoring drug resistance by upregulating MDR1. Journal of Cancer. 2021;12(10):2952-9. 5. Leukapheresis and Hyperleukocytosis, Past and Future. International journal of general medicine. 2021;14:3457-67. 6. Upfront Treatment of Pediatric High-Risk Neuroblastoma With Chemotherapy, Surgery, and Radiotherapy Combination: The CCCG-NB-2014 Protocol. Front Oncol . 2021 Nov 15;11:745794. doi: 10.3389/fonc.2021.745794. 7. Treatment of Pediatric Inflammatory Myofibroblastic Tumor: The Experience from China Children’s Medical Center. Children. 2022; 9(3):307.

Affiliations

Hubei University of Medicine

Shiyan, Hubei, China

Department of Oncology

Honors and Awards

No honors or awards have been shared yet.

Experience

No experience has been shared yet.